Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001962918-24-000134
Filing Date
2024-11-27
Accepted
2024-11-27 17:17:21
Documents
1
Period of Report
2024-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1732745834.html 4  
1 FORM 4 wk-form4_1732745834.xml 4 3944
  Complete submission text file 0001962918-24-000134.txt   5403
Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BOULEVARD,SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address
Murugan Amar (Reporting) CIK: 0001809916 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41696 | Film No.: 241512418

Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Issuer) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)